Clinical Trial Update: TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients [NA]

View source ↗

Summary

This entry provides an update on a clinical trial evaluating transarterial chemoembolization (TACE) with or without stereotactic body radiotherapy (SBRT) as bri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Hepatocellular Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING